In related news, the American Diabetes Association released new consensus considerations and good-practice points for use of ...

Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...

In a groundbreaking new study, the active ingredient in Ozempic was found to be so effective at treating arthritis that ...

For years, scientists have observed a connection between type 2 diabetes and an increased risk of dementia, particularly ...

Study participants were randomly assigned 2:1 to receive once-weekly subcutaneous semaglutide 2.4mg or placebo alongside standard of care. The primary endpoints for part 1 were resolution of ...

Fewer patients experienced a first hospital admission for any indication and for serious adverse events while on semaglutide.

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated ...

With a positive readout for metabolic dysfunction-associated steatohepatitis (MASH) now in the bag, Novo Nordisk is gearing ...

Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of ...

Looking to drop those stubborn pounds? The weight loss world is buzzing about a game-changing medication that's helping ...

Topline results were announced from a cardiovascular outcomes study evaluating oral semaglutide in patients with type 2 diabetes.

Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But ...